The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 29, 1989
Filed:
Sep. 25, 1986
Applicant:
Inventors:
Claude Mazuel, Riom, FR;
Marie-Claire Friteyre, Riom, FR;
Assignee:
Merck & Co., Inc., Rahway, NJ (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K / ; A61K / ;
U.S. Cl.
CPC ...
514 54 ; 514912 ; 514913 ; 514915 ; 514944 ; 536-11 ; 536114 ; 536123 ;
Abstract
The present invention relates to a pharmaceutical composition intended for contacting with a physiological liquid characterized in that said composition is intended to be administered as a non-gelled liquid form and is intended to gel in situ, this composition containing at least one polysaccharide in aqueous solution, of the type which undergoes liquid-gel phase transition gelling in situ under the effect of an increase in the ionic strength of said physiological liquid.
Published as:
DK469886D0; NO863916D0; PT83471A; GR862444B; IE862481L; DK469886A; FI863990L; NO863916L; CN86106637A; AU6318986A; FR2588189A1; KR870003773A; EP0227494A1; ZA867464B; JPS62181228A; DE227494T1; ES2002401A6; PT83471B; FR2588189B1; US4861760A; NZ217662A; AU595240B2; IL80156A; CA1280367C; EP0227494B1; ATE72990T1; DE3684121D1; NO173212B; NO173212C; KR940000229B1; IE59464B1; FI91217B; HK42594A; FI91217C; JPH0667853B2; NO1995003I1; DK170500B1; CY1779A; LV5725A4; LU88694I2; LV5725B4; NL950012I1; CN1046094C;